What percentage of people using self-care for seborrheic dermatitis saw worse symptoms in Wise Pharmaceutical's survey of 12,183 individuals?

In Wise Pharmaceutical's survey of 12,183 people, 91.6% who self-treated seborrheic dermatitis experienced worsening symptoms.

How many participants were involved in the Wise Pharmaceutical study on seborrheic dermatitis self-care conducted in 2023?

The Wise Pharmaceutical study on seborrheic dermatitis self-care included 12,183 participants as part of its national survey.

What term did Wise Pharmaceutical use to describe improper self-treatment of seborrheic dermatitis based on 12,183 survey responses?

Wise Pharmaceutical coined the term 'mis-care' to describe improper self-treatment of seborrheic dermatitis observed in the survey of 12,183 people.

Why does Wise Pharmaceutical warn against using social media advice for seborrheic dermatitis treatment according to their 2023 survey findings?

Wise Pharmaceutical warns against social media advice because their 2023 survey found it contributes to mis-care and symptom worsening in seborrheic dermatitis.

What was the main cause of symptom worsening in 91.6% of cases in Wise Pharmaceutical's 12,183-person seborrheic dermatitis study?

The main cause of symptom worsening in 91.6% of cases was self-care without medical guidance, as reported in Wise Pharmaceutical's 12,183-person study.

AI News NQ Analysis

[National Survey of 12,183 People] 91.6% of Those Who Experienced Self-Care for Seborrheic Dermatitis Experienced Worsening Symptoms – Wise Pharmaceutical Visualizes the Reality of "Mis-Care"

NQ Score 100/100

AI Summary (NQ-processed)

A survey by Wise Pharmaceutical revealed that 91.6% of individuals with seborrheic dermatitis who self-treated without medical guidance experienced symptom worsening. The study highlights that relying on easily accessible information from social media, blogs, and videos correlates with a higher likelihood of worsening symptoms, defining this phenomenon as "mis-care" due to the complex nature of the condition and information overload.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What percentage of people using self-care for seborrheic dermatitis saw worse symptoms in Wise Pharmaceutical's survey of 12,183 individuals?: A: In Wise Pharmaceutical's survey of 12,183 people, 91.6% who self-treated seborrheic dermatitis experienced worsening symptoms.
Q: How many participants were involved in the Wise Pharmaceutical study on seborrheic dermatitis self-care conducted in 2023?: A: The Wise Pharmaceutical study on seborrheic dermatitis self-care included 12,183 participants as part of its national survey.
Q: What term did Wise Pharmaceutical use to describe improper self-treatment of seborrheic dermatitis based on 12,183 survey responses?: A: Wise Pharmaceutical coined the term 'mis-care' to describe improper self-treatment of seborrheic dermatitis observed in the survey of 12,183 people.
Q: Why does Wise Pharmaceutical warn against using social media advice for seborrheic dermatitis treatment according to their 2023 survey findings?: A: Wise Pharmaceutical warns against social media advice because their 2023 survey found it contributes to mis-care and symptom worsening in seborrheic dermatitis.
Q: What was the main cause of symptom worsening in 91.6% of cases in Wise Pharmaceutical's 12,183-person seborrheic dermatitis study?: A: The main cause of symptom worsening in 91.6% of cases was self-care without medical guidance, as reported in Wise Pharmaceutical's 12,183-person study.